InvestorsHub Logo
Followers 95
Posts 3767
Boards Moderated 0
Alias Born 06/14/2012

Re: noreen post# 2805

Wednesday, 05/24/2017 5:25:55 PM

Wednesday, May 24, 2017 5:25:55 PM

Post# of 18220
Makes sense for the most part. I think if dilution or sellers came out after the news, we would have seen a push down on larger volume. So far we're floating around between the 50ma and 200ma on light volume. Not a bad thing...was just expecting a double volume kind of day on the 8-k.

I guess I look at this like a blessing. Less eyes on this than I originally thought. Makes buying ops short term. Can't imagine we don't see long term growth. So far from when I jumped on management is delivering! They say profitable by EOY and dilution loans do to. I can wait 2-3 quarters to see this proof.

One thing I did notice is that the word "contracts" was plural. I like that.

Reading back through the Jan 30 letter to shareholders, its all lining up. All of it. Major cash flow by end of Q2, profitable by end of 2017, self-funded by end of 2017, fast track approvals from other African countries, using NAFDAC approval as fast track for MENK approval for cancer, and possible Cytocom spin off. That's a lot. BUT, in all fairness I think investors are shy here. Due to 2014 claims of big revs which didn't happen, and more dilution followed, I can see how people want to see the rev proof first.

But I keep remembering that there are some big backers here and it looks like the time is now. I'm glad I'm in mostly in the low 3s as it makes holding this long term a no-brainer.




"One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute." - William Feather.